The German Cardiometabolic Cost Database - A methodological approach to assess cost data for modelling cost-effectiveness of treatment regimes for patients with multiple cardiometabolic risk factors

被引：0
|
作者：
Fuchs, S. M.
Klauss, V
Dieterle, C.
Wasem, J.
Aidelsburger, P.
机构：
[1] Carem GmbH, Sauerlach, Germany
[2] Univ Munich, Munich, Germany
[3] Univ Duisburg Essen, Essen, Germany
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63691-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A360 / A360
页数：1
相关论文
共 50 条
  • [1] A methodological approach to assess cost data in the context of a decision analytic model to evaluate the cost-effectiveness of the treatment of the metabolic syndrome
    Aidelsburger, P
    Wasem, J
    VALUE IN HEALTH, 2005, 8 (06) : A68 - A68
  • [2] Cost-effectiveness of treating cardiometabolic patients with rimonabant (Acomplia®) in a Danish setting
    Knudsen, M. S.
    Poulsen, P. B.
    Serup-Hansen, N.
    VALUE IN HEALTH, 2006, 9 (06) : A324 - A325
  • [3] Cost and cost-effectiveness of the 'Stand and Move at Work' multicomponent intervention to reduce workplace sedentary time and cardiometabolic risk
    Michaud, Tzeyu L.
    You, Wen
    Estabrooks, Paul A.
    Leonard, Krista
    Rydell, Sarah A.
    Mullane, Sarah L.
    Pereira, Mark A.
    Buman, Matthew P.
    SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2022, 48 (05) : 399 - 409
  • [4] Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care
    Ilse F Badenbroek
    Daphne M Stol
    Marcus MJ Nielen
    Monika Hollander
    Roderik A Kraaijenhagen
    G Ardine de Wit
    François G Schellevis
    Niek J de Wit
    BMC Family Practice, 15
  • [5] Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care
    Badenbroek, Ilse F.
    Stol, Daphne M.
    Nielen, Marcus M. J.
    Hollander, Monika
    Kraaijenhagen, Roderik A.
    de Wit, G. Ardine
    Schellevis, Francois G.
    de Wit, Niek J.
    BMC FAMILY PRACTICE, 2014, 15
  • [6] Erratum to: Design of the INTEGRATE study: effectiveness and cost-effectiveness of a cardiometabolic risk assessment and treatment program integrated in primary care
    Ilse F Badenbroek
    Daphne M Stol
    Marcus MJ Nielen
    Monika Hollander
    Roderik A Kraaijenhagen
    G Ardine de Wit
    François G Schellevis
    Niek J de Wit
    BMC Family Practice, 17
  • [7] Assessing cost-effectiveness before marketing: A case-study of rimonabant for reduction of cardiometabolic risk in patients with dyslipidemia in the UK
    Caro, J. J.
    Getsios, D.
    Proskorovsky, I
    Nicholls, C.
    McEwan, P.
    VALUE IN HEALTH, 2006, 9 (06) : A193 - A193
  • [8] COST-EFFECTIVENESS OF THE US FDA ADDED SUGAR LABELING POLICY FOR IMPROVING CARDIOMETABOLIC HEALTH: MICROSIMULATION MODELLING STUDY
    Kypridemos, C.
    Huang, Y.
    Liu, J.
    Lee, Y.
    Pearson-Stuttard, J.
    Collins, B.
    Bandosz, P.
    Capewell, S.
    O'Flaherty, M.
    Micha, R.
    Whitsel, L.
    Wilde, P.
    Mozaffarian, D.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2018, 72 : A2 - A2
  • [9] Cost-effectiveness and budget impact of a lifestyle intervention to improve cardiometabolic health in patients with severe mental illness
    Looijmans, Anne
    Jorg, Frederike
    Bruggeman, Richard
    Schoevers, Robert A.
    Corpeleijn, Eva
    Feenstra, Talitha L.
    van Asselt, A. D. I.
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2020, 7 (01) : 131 - 138
  • [10] Cost-effectiveness analysis in long-term treatment of risk factors
    Szucs, TD
    Gutzwiller, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 128 (49) : 1958 - 1964
12345